Natus Medical Incorporated
Vimab Group AB (publ), together with its subsidiaries, operates in the energy service, and industrial and environmental technology industries in Sweden and internationally. The company sells energy storage systems and fittings, as well as valve or spare part; and manufactures various products, such as portable valve grinding equipment, electric steam boilers, customized steam systems, molds, tool… Read more
Market Cap & Net Worth: Natus Medical Incorporated (NM4)
Natus Medical Incorporated (F:NM4) has a market capitalization of $17.04 Million (€16.60 Million) as of March 18, 2026. Listed on the F stock exchange, this Germany-based company holds position #33858 globally and #3851 in its home market, demonstrating a 114.11% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Natus Medical Incorporated's stock price €0.35 by its total outstanding shares 47561972 (47.56 Million).
Natus Medical Incorporated Market Cap History: 2026 to 2026
Natus Medical Incorporated's market capitalization history from 2026 to 2026. Data shows growth from $17.04 Million to $17.04 Million (0.00% CAGR).
Natus Medical Incorporated Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Natus Medical Incorporated's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of NM4 by Market Capitalization
Companies near Natus Medical Incorporated in the global market cap rankings as of March 18, 2026.
Key companies related to Natus Medical Incorporated by market ranking:
- Experian plc PK (OTCQX:EXPGY): Ranked #569 globally with a market cap of $37.67 Billion USD.
- Verisk Analytics Inc (NASDAQ:VRSK): Ranked #726 globally with a market cap of $28.03 Billion USD.
- Equifax Inc (NYSE:EFX): Ranked #865 globally with a market cap of $22.83 Billion USD.
- SGS SA (PINK:SGSOF): Ranked #1186 globally with a market cap of $15.81 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #569 | Experian plc PK | OTCQX:EXPGY | $37.67 Billion | $41.30 |
| #726 | Verisk Analytics Inc | NASDAQ:VRSK | $28.03 Billion | $203.79 |
| #865 | Equifax Inc | NYSE:EFX | $22.83 Billion | $187.32 |
| #1186 | SGS SA | PINK:SGSOF | $15.81 Billion | $95.84 |
Natus Medical Incorporated Historical Marketcap From 2026 to 2026
Between 2026 and today, Natus Medical Incorporated's market cap moved from $17.04 Million to $ 17.04 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €17.04 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Natus Medical Incorporated was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $17.04 Million USD |
| MoneyControl | $17.04 Million USD |
| MarketWatch | $17.04 Million USD |
| marketcap.company | $17.04 Million USD |
| Reuters | $17.04 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.